Atlas FDA

Synvisc One

FDA premarket approval P940015/S044 · decided 2019-01-16

Approval details

PMA number
P940015
Supplement
S044
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Synvisc One
Generic name
Acid, hyaluronic, intraarticular
Applicant
Sanofi Genzyme Corp.
Date received
2018-12-17
Decision date
2019-01-16
Days to decision
30 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Cambridge, MA
Statement
Modified sterilization cycles and loads for the sterilization of equipment parts used in the manufacturing of Synvisc and Synvisc-One.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.